Welcome to our searchable resource and literature collection on safer supply and related topics.
Found a broken link? Links do move around, so if you find one here that's broken, please let us know through the Contact form.
Welcome to our searchable resource and literature collection on safer supply and related topics.
Found a broken link? Links do move around, so if you find one here that's broken, please let us know through the Contact form.
This study is based on an evaluation of a safer supply program (SSP) in a medium-sized urban centre with a large catchment area that includes rural and Indigenous communities.
We aimed to determine the extent to which uptake and discontinuation of an initial attempt at a prescribed safer supply (PSS) program were influenced through networks of prescribers.
The aim of this submission is to clarify the research and statistics behind injection-related infections among individuals on safer opioid supply (SOS)--daily dispensed immediate-release hydromorph
We examined the number and characteristics of high-volume buprenorphine prescribers and the nature of their buprenorphine prescribing from 2009 to 2018.
Canadian Opioid Agonist Therapy (OAT) guidelines outline take-home dose (THD) criteria, yet, OAT prescribers use their clinical judgement to decide whether an individual is ‘clinically stable’ to r
To identify individual and initial prescription-related factors associated with an increased risk for opioid-related misuse, poisoning and dependence (MPD) in patients with non-cancer pain.
We compared prescription opioid pain medication dispensing for patients with schizophrenia (SZ) or bipolar disorder (BD) versus controls over 5 years, to assess opioid dispensing trends and comorbi
Did trends in postrelease treatment and outcomes for opioid use disorder change after Massachusetts prison system implemented buprenorphine treatment during incarceration?
To develop an individual-level prediction tool for risk of return to use in opioid use disorder.
To evaluate the impact of the tightened Pharmaceutical Benefits Scheme (PBS) prescribing rules for immediate release (IR) and controlled release (CR) opioid medicines (1 June 2020), which also elim
This personal view paper summarises substantial gaps in our understanding of opioid withdrawal that are likely to continue to limit major advancements in its treatment.
To examine the relationship between the total number of months with an active buprenorphine prescription (retention) and the odds of an adverse outcome within the 12 months following an index non-f
The current study uses narrative analysis and framing theory to explore the series "Dopesick" (2021), discussing its portrayal of the people and themes involved in the USA opioid crisis.
This study explores perceptions and experiences of overdose among people who smoke drugs.